Thoracolaparoscopic esophagectomy for esophageal cancer: case series and perioperative outcomes in a National Hospital of Peru (2022–2026)
Keywords:
Esophageal cancer, Esophageal squamous cell carcinoma, Esophageal adenocarcinoma, laparoscopic surgery, thoracoscopic surgery, cervicotomyAbstract
Introduction: Thoracoscopic–laparoscopic esophagectomy is a minimally invasive approach for esophageal cancer, associated with reduced morbidity and adequate oncologic radicality, and represents a cornerstone of multimodal curative treatment. Objective: To evaluate the initial outcomes of patients undergoing thoracoscopic–laparoscopic esophagectomy in a national referral hospital in Peru. The Study: Case series with 30–60-day follow-up. Patients with resectable esophageal cancer underwent thoracoscopic, laparoscopic, and cervical approaches with two-field lymphadenectomy (2022–2026). Results: Eleven patients were included (54.5% female), with a mean age of 61.9 years. Mean operative time was 371.5 minutes and mean blood loss was 108.8 mL. No intraoperative complications were reported. Major postoperative complications included pneumonia (45.5%) and anastomotic leak (36.4%). Mean hospital stay was 61.4 days. No mortality was observed during follow-up. Findings: Thoracoscopic–laparoscopic esophagectomy is feasible and safe in a real-world referral setting, with acceptable perioperative outcomes and no short-term mortality.
Downloads
References
1. Fernández-Montes A, Alcaide J, Alsina M, Custodio AB, Franco LF, Gallego Plazas J, et al. SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021). Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. abril de 2022;24(4):658-69. doi:10.1007/s12094-022-02801-2
2. Cintra ST, Pérez AC, Pérez SC. Cáncer de esófago. Revisión actualizada. Revista Información Científica. 2016;95(4):635-46.
3. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. julio de 2020;159(1):335-349.e15. doi:10.1053/j.gastro.2020.02.068
4. Bosch DJ, Muijs CT, Mul VEM, Beukema JC, Hospers GAP, Burgerhof JGM, et al. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients. Ann Surg Oncol. febrero de 2014;21(2):605-11. doi:10.1245/s10434-013-3316-8
5. Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, et al. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. octubre de 2022;33(10):992-1004. doi:10.1016/j.annonc.2022.07.003
6. Montiel-Roa AJ, Dragotto-Galván A, Mereles LM, Mora-Garbini SD, Rojas-Franco BM, Balmaceda-Rodrigues BB, et al. Prevalencia del Cáncer de Esófago y su tratamiento Quirúrgico en un Hospital de alta complejidad durante el periodo enero 2016- diciembre 2018. Cir Paraguaya. abril de 2020;44(1):12-5. doi: 10.18004/sopaci.2020.abril.12-15
7. Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. septiembre de 2018;88(3):413-26. doi:10.1016/j.gie.2018.04.2352
8. Zunñiga Sequeira T, Cruz Brenes A. Revisión Bibliográfica de Esofago. Rev Médica Costa Rica Centroam. 2012;LXIX(604):539-44.
9. Tejera D, Micol M, Laino A, Verga F, Alzugaray J, Bertullo M, et al. Complicaciones y mortalidad en esofagectomía por cáncer en unidades de medicina intensiva. Rev Médica Urug. septiembre de 2015;31(3):155-64.
10. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. julio de 2011;12(7):681-92. doi:10.1016/S1470-2045(11)70142-5
11. American Cancer Society. Surgery [Internet]. [citado 1 de febrero de 2026]. Surgery for Esophageal Cancer. Disponible en: https://www.cancer.org/cancer/types/esophagus-cancer/treating/surgery.html doi:1.800.227.2345
12. Miao Y. Longitudinal study of postoperative symptoms and quality of life in patients with esophageal squamous cell carcinoma. Diseases of the Esophagus [Internet]. 1 de septiembre de 2022 [citado 19 de marzo de 2026];35(2). doi:10.1093/dote/doac051.124
13. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. febrero de 1992;37(1):7-11. PubMed PMID: 1573620.
14. Rice T, Patil D. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Annals of Cardiothoracic Surgery [Internet]. 2017 [citado 19 de marzo de 2026];6(2). doi:10.21037/acs.2017.03.14
15. Bollschweiler E, Hölscher A, Hölscher M. Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment - Chinese Journal of Cancer Research. Chinese Journal of Cancer Research [Internet]. junio de 2015 [citado 5 de enero de 2026];27(3). Disponible en: https://www.cjcrcn.org/article/6404.html
16. Boyle E, Elliott J, Greene C, Murphy C, Donlon N, Donohoe C, et al. Gastrointestinal quality of life, body composition and influencing factors, in esophageal cancer survivors following curative esophagectomy. Diseases of the Esophagus. 1 de septiembre de 2023;36(Supplement_2):doad052.241. doi:10.1093/dote/doad052.241
17. Mao YS, Gao SG, Li Y. Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial(NST1501). Annals of Translational Medicine [Internet]. agosto de 2022 [citado 19 de marzo de 2026];10(16). doi:10.21037/atm-22-3810
18. Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, et al. Benchmarking Complications Associated with Esophagectomy. Ann Surg. febrero de 2019;269(2):291. doi:10.1097/SLA.0000000000002611
19. Grimminger. Diagnosis, assessment, and management of surgical complications following esophagectomy. Annals of the New York Academy of Sciences. diciembre de 2018;1334(1):254-73. doi: 10.1111/nyas.13920
20. Palanivelu C, Dey S, Sabnis S, Gupta R, Cumar B, Kumar S, et al. Robotic-assisted minimally invasive oesophagectomy for cancer: An initial experience. J Minimal Access Surg. septiembre de 2019;15(3):234. doi:10.4103/jmas.JMAS_7_18
21. Oesophago-Gastric Anastomosis Study Group on behalf of the West Midlands Research Collaborative. Rates of Anastomotic Complications and Their Management Following Esophagectomy Results of the Oesophago-Gastric Anastomosis Audit (OGAA). Annals of Surgery. febrero de 2022;275(2):382-91.
22. Chen KN. Managing complications I: leaks, strictures, emptying, reflux, chylothorax. Journal of Thoracic Disease [Internet]. mayo de 2014 [citado 19 de marzo de 2026];6(3). doi:10.3978/j.issn.2072-1439.2014.03.36
